ESMO 2019 | First-line treatment guidelines: combination strategy

Laurence Albiges, MD, PhD, Gustave Roussy Institute, Villejuif, France, outlines the new guidelines for first-line treatment, based on the KEYNOTE and JAVELIN studies (NCT01772004), stating that combination strategy should be offered to all patients. This interview was recorded at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.